The effect of definity on systemic and pulmonary hemodynamics in patients

Journal of the American Society of Echocardiography

Volumn 25, Issue 5, 2012, Pages 584-588

  Wei, Kevin ^a   Main, Michael L ^b   Lang, Roberto M ^c   Klein, Allan ^d   Angeli, Stephen ^e   Panetta, Carmelo ^f   Mikati, Issam ^g   Lee, L Veronica ^h   Bernstein, Jonathan A ⁱ   Ahmad, Masood ^j  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e Holy Name Hospital   (United States)

^f Park Nicollet Heart and Vascular Center   (United States)

^g NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^h Clinical Research   (United States)

ⁱ UNIVERSITY OF CINCINNATI   (United States)

^j UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

more..

Author keywords

Contrast echocardiography; Hemodynamics; Pulmonary artery pressure; Safety

Indexed keywords

ALBUMIN; AMINOTRANSFERASE; BILIRUBIN; CALCIUM; CHOLESTEROL; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; CREATINE KINASE; CREATINE KINASE MB; CREATININE; ELECTROLYTE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MAGNESIUM; PERFLUTREN; PHOSPHORUS; PROTEIN; TRIACYLGLYCEROL; TROPONIN I; TRYPTASE; URIC ACID;

ADULT; AGED; ARTICLE; BACKACHE; BLOOD CELL COUNT; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG SAFETY; FEMALE; HEADACHE; HEART OUTPUT; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; MALE; MULTICENTER STUDY; NECK PAIN; PHASE 4 CLINICAL TRIAL; PULMONARY ARTERY OCCLUSION PRESSURE; SYSTEMIC HEMODYNAMICS; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG HYPERSENSITIVITY; ECHOCARDIOGRAPHY; FEMALE; FLUOROCARBONS; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PROSPECTIVE STUDIES; PULMONARY WEDGE PRESSURE; RISK ASSESSMENT; SAFETY MANAGEMENT; TIME FACTORS;

EID: 84860237550     PISSN: 08947317     EISSN: 10976795     Source Type: Journal    
DOI: 10.1016/j.echo.2012.01.019     Document Type: Article

References (14)

1. J.R. Lindner, and K. Wei Action or over-reaction? JACC Cardiovasc Imaging 1 2008 109 110
2. M.L. Main, J.H. Goldman, and P.A. Grayburn Thinking outside the "box" - the ultrasound contrast controversy J Am Coll Cardiol 50 2007 2434 2437 (Pubitemid 350266276)
3. P.A. Grayburn, J.M. Erickson, J. Escobar, L. Womack, and C.E. Velasco Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia J Am Coll Cardiol 26 1995 1340 1347
4. J. Szebeni Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity Toxicology 216 2005 106 121 (Pubitemid 41712000)
5. S.D. Kirkton, H. Wagner, M.M. Landicho, J.J. Struthers, N. Busan, and P.D. Wagner Effects of Imagent on pulmonary hemodynamics and gas exchange in dogs Ultrasound Med Biol 32 2006 949 959 (Pubitemid 43903081)
6. Y. Yamaya, K. Niizeki, J. Kim, P.L. Entin, H. Wagner, and P.D. Wagner Effects of Optison on pulmonary gas exchange and hemodynamics Ultrasound Med Biol 28 2002 1005 1013 (Pubitemid 36158836)
7. M.L. Main, A. Ehlgen, T.R. Coggins, B.A. Morris, P. Lanza, and T.M. Tremblay Pulmonary hemodynamic effects of dipyridamole infusion in patients with normal and elevated pulmonary artery systolic pressure receiving PB127 J Am Soc Echocardiogr 19 2006 1038 1044 (Pubitemid 44118685)
8. P. Soman, A. Lahiri, and R. Senior Safety of an intravenous second generation contrast agent in patients with severe left ventricular dysfunction Heart 84 2000 634 635
9. K. Wei, S.L. Mulvagh, L. Carson, R. Davidoff, R. Gabriel, and R.A. Grimm The safety of Definity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses J Am Soc Echocardiogr 11 2008 1202 1206
10. S.S. Abdelmonein, M. Bernier, C.G. Scott, A. Dhoble, S.A.C. Ness, and M.E. Hagen Safety of contrast agent use during stress echocardiography in patients with elevated right ventricular systolic pressure Circ Cardiovasc Imaging 3 2010 240 248
11. L.L. Kusnetzky, A. Khalid, T.M. Khumri, T.G. Moe, P.G. Jones, and M.L. Main Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. Results in 18,671 consecutive studies J Am Coll Cardiol 51 2008 1704 1706
12. M.L. Main, A.C. Ryan, T.E. Davis, M.P. Albano, L.L. Kusnetzky, and M. Hibberd Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients) Am J Cardiol 102 2008 1742 1746
13. A. Exuzides, M.L. Main, C. Colby, P.A. Grayburn, S.B. Feinstein, and J.H. Goldman A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent JACC Cardiovasc Imaging 3 2010 578 585
14. M. Kurt, K.A. Shaikh, L. Peterson, K.M. Kurrelmeyer, G. Shah, and S.F. Nagueh Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort J Am Coll Cardiol 53 2009 802 810